MKI67 and neoplasm: At the same time, the IHC results of the tumor cell proliferation marker Ki67 (Figure 5K) showed that the Ki67 score of tumor cells in the MASKv+Mag group was significantly reduced, indicating that the tumor proliferation ability was weakened after treatment with SLCV+Mag.